- Telehealth visits
Christine Higham, MD
Pediatric Hematology-Oncology- Telehealth visits
Christine Higham, MD
Pediatric Hematology-Oncology- Telehealth visits
On this page
About me
Dr. Christine Higham is a specialist in blood and bone marrow transplantation for pediatric patients.
Higham studies thrombotic microangiopathy, a serious condition that can develop after a bone marrow transplant. Her research aims to discover why this damage to blood vessels may occur and how to prevent it.
Higham earned her medical degree from Boston University School of Medicine. She completed a residency in pediatrics at Northwestern University Feinberg School of Medicine. She then completed a fellowship in pediatric hematology and oncology at Children's National Hospital and a fellowship in pediatric bone marrow transplantation at UCSF.
Higham is a member of the American Society of Clinical Oncology, American Society of Pediatric Hematology/Oncology and Phi Beta Kappa Society.
Education & training
Board certification
- Pediatric Hematology-Oncology, American Board of Pediatrics
- Pediatrics, American Board of Pediatrics
Fellowship
- Ped. Hema/Oncology, Children's National Medical Center
Residency
- Pediatrics, McGaw Medical Center of Northwestern University
Internship
- Pediatrics, McGaw Medical Center of Northwestern University
Degree
- MD, Boston University School of Medicine
Academic Title
- Health Sciences Clinical Professor
My expertise
Specialties
- Pediatric Hematology-Oncology
Locations
My research
Clinical trials
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALLOpens in a new window
Recruiting
The primary objective of this study is the two Year Event-free Survival for patients with high-risk or recurrent B-ALL who proceed to HCT and who are NGS-MRD n...
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.